To The Moon

Here’s an inside look at my small-cap portfolio & the reasons behind each of my holdings as we head into 2025 🧐

• $AST SpaceMobile, Inc.(ASTS)$ -- The American Tower of Space, building a global satellite-to-cellphone network to address the $1T+ connectivity market.

• $Rocket Lab USA, Inc.(RKLB)$ -- The FedEx of Space, providing end-to-end satellite launch, manufacturing & space data solutions for the $400B space economy.

• $IONQ Inc.(IONQ)$ -- Positioning itself as a leader in quantum computing by offering scalable, trapped-ion quantum systems for high-value use cases such as drug discovery, logistics optimization & financial modeling -- addressing a projected $65B quantum computing market by 2030.

• $Jumia Technologies AG(JMIA)$ -- Building a comprehensive logistics & fintech ecosystem to drive e-commerce growth in Africa -- targeting the continent’s underpenetrated $75B online retail market.

• $Eos Energy Enterprises Inc.(EOSE)$ -- Developing zinc-based long-duration energy storage systems for grid-scale renewable energy -- targeting a $3B market opportunity in renewable integration and storage.

• $Enovix Corporation(ENVX)$ -- Innovating next-generation lithium-ion battery designs for consumer electronics & EVs -- targeting a $90B battery market as demand for energy-dense and durable solutions grows.

• $Aehr Test(AEHR)$ -- Driving the adoption of silicon carbide (SiC) technology with proprietary test systems that support scaling in EV manufacturing, AI data centers & renewable energy industries.

• $Navitas Semiconductor Corp(NVTS)$ -- Redefining power efficiency in EVs, 5G & renewable energy markets through advanced gallium nitride (GaN) semiconductors -- targeting faster adoption in the $1B GaN market.

• $Indie Semiconductor Inc.(INDI)$ -- Delivering system-on-chip (SoC) semiconductor solutions tailored for the growing demand in advanced driver-assistance systems (ADAS) & EVs.

• $Recursion Pharmaceuticals, Inc.(RXRX)$ -- Leveraging AI-driven drug discovery to streamline pharmaceutical R&D, targeting breakthrough treatments & partnerships in the $1.5T global drug market.

• $Viking Therapeutics(VKTX)$ -- Advancing late-stage clinical programs in metabolic disorders like NASH & obesity, with a pipeline focused on unlocking multi-billion-dollar opportunities in the endocrine therapeutics market.

• $Intellia Therapeutics(NTLA)$ -- Developing transformative CRISPR-based therapies, with initial programs targeting multi-billion-dollar markets in genetic diseases such as sickle cell anemia & hereditary ATTR amyloidosis.

• $PACER INDUSTRIAL REAL ESTATE ETF(INDS)$ -- Powering drones & industrial IoT with private wireless networks, targeting utilities, logistics, agriculture & the $100B+ connectivity market.

• $Beam Therapeutics, Inc.(BEAM)$ -- Developing precision gene-editing technologies using base-editing techniques to target genetic disorders -- positioning itself for a share in the $5B gene therapy market.

• $DELCATH SYSTEMS INC(DCTH)$ -- Pioneering hepatic artery infusion (HAI) therapies for liver cancer, with its flagship product poised to address unmet needs in a $3B global market.

• $Ginkgo Bioworks Holdings Inc.(DNA)$ -- Expanding its synthetic biology platform to enable cost-efficient cell programming for industries including biopharma, agriculture & manufacturing -- addressing a TAM exceeding $100B.

• $Fastly, Inc.(FSLY)$ -- Providing edge cloud infrastructure for real-time processing, security & delivery in e-commerce, fintech & SaaS -- addressing a $15B market.

• $Nano-X Imaging Ltd.(NNOX)$ -- Transforming medical imaging with cost-effective digital X-ray technology aimed at broadening access to diagnostic imaging in a $30B global market.

• $RxSIGHT, INC.(RXST)$ -- Focusing on innovative solutions in urology and endoscopy, with a growing presence in minimally invasive medical devices for an $8B addressable market.